company background image
IOSP

InnospecNasdaqGS:IOSP Stock Report

Last Price

US$95.47

Market Cap

US$2.4b

7D

-2.6%

1Y

-0.04%

Updated

20 Jan, 2022

Data

Company Financials +
IOSP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance4/6
Financial Health6/6
Dividends1/6

IOSP Stock Overview

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally.

Innospec Competitors

Albemarle

NYSE:ALB

US$25.4b

Celanese

NYSE:CE

US$18.0b

Eastman Chemical

NYSE:EMN

US$16.4b

Ashland Global Holdings

NYSE:ASH

US$5.6b

Price History & Performance

Summary of all time highs, changes and price drops for Innospec
Historical stock prices
Current Share PriceUS$95.47
52 Week HighUS$107.73
52 Week LowUS$81.00
Beta1.36
1 Month Change7.58%
3 Month Change7.91%
1 Year Change-0.042%
3 Year Change41.44%
5 Year Change32.51%
Change since IPO469.97%

Recent News & Updates

Jan 06
Is There Now An Opportunity In Innospec Inc. (NASDAQ:IOSP)?

Is There Now An Opportunity In Innospec Inc. (NASDAQ:IOSP)?

Innospec Inc. ( NASDAQ:IOSP ), might not be a large cap stock, but it saw a decent share price growth in the teens...

Dec 19
Innospec (NASDAQ:IOSP) Has More To Do To Multiply In Value Going Forward

Innospec (NASDAQ:IOSP) Has More To Do To Multiply In Value Going Forward

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...

Nov 06
Innospec (NASDAQ:IOSP) Will Pay A Larger Dividend Than Last Year At US$0.59

Innospec (NASDAQ:IOSP) Will Pay A Larger Dividend Than Last Year At US$0.59

Innospec Inc.'s ( NASDAQ:IOSP ) dividend will be increasing to US$0.59 on 24th of November. Although the dividend is...

Shareholder Returns

IOSPUS ChemicalsUS Market
7D-2.6%-4.4%-4.0%
1Y-0.04%11.9%6.6%

Return vs Industry: IOSP underperformed the US Chemicals industry which returned 12% over the past year.

Return vs Market: IOSP underperformed the US Market which returned 7.7% over the past year.

Price Volatility

Is IOSP's price volatile compared to industry and market?
IOSP volatility
IOSP Average Weekly Movement4.2%
Chemicals Industry Average Movement5.6%
Market Average Movement6.6%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.4%

Stable Share Price: IOSP is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: IOSP's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19381,900Patrick Williamshttps://www.innospecinc.com

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. It operates through Fuel Specialties, Performance Chemicals, and Oilfield Services segments. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels.

Innospec Fundamentals Summary

How do Innospec's earnings and revenue compare to its market cap?
IOSP fundamental statistics
Market CapUS$2.35b
Earnings (TTM)US$91.80m
Revenue (TTM)US$1.38b

25.6x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IOSP income statement (TTM)
RevenueUS$1.38b
Cost of RevenueUS$968.00m
Gross ProfitUS$413.00m
ExpensesUS$321.20m
EarningsUS$91.80m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Feb 15, 2022

Earnings per share (EPS)3.72
Gross Margin29.91%
Net Profit Margin6.65%
Debt/Equity Ratio0%

How did IOSP perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

29%

Payout Ratio

Valuation

Is Innospec undervalued compared to its fair value and its price relative to the market?

25.63x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: IOSP ($95.47) is trading above our estimate of fair value ($66.21)

Significantly Below Fair Value: IOSP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: IOSP is poor value based on its PE Ratio (25.6x) compared to the US Chemicals industry average (21.1x).

PE vs Market: IOSP is poor value based on its PE Ratio (25.6x) compared to the US market (16.9x).


Price to Earnings Growth Ratio

PEG Ratio: IOSP is poor value based on its PEG Ratio (1.2x)


Price to Book Ratio

PB vs Industry: IOSP is good value based on its PB Ratio (2.4x) compared to the US Chemicals industry average (2.5x).


Future Growth

How is Innospec forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

22.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IOSP's forecast earnings growth (22.1% per year) is above the savings rate (2%).

Earnings vs Market: IOSP's earnings (22.1% per year) are forecast to grow faster than the US market (13.1% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: IOSP's revenue (8.9% per year) is forecast to grow slower than the US market (9.3% per year).

High Growth Revenue: IOSP's revenue (8.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if IOSP's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Innospec performed over the past 5 years?

-5.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IOSP has high quality earnings.

Growing Profit Margin: IOSP's current net profit margins (6.6%) are higher than last year (2.9%).


Past Earnings Growth Analysis

Earnings Trend: IOSP's earnings have declined by 5% per year over the past 5 years.

Accelerating Growth: IOSP's earnings growth over the past year (146.8%) exceeds its 5-year average (-5% per year).

Earnings vs Industry: IOSP earnings growth over the past year (146.8%) exceeded the Chemicals industry 17.5%.


Return on Equity

High ROE: IOSP's Return on Equity (9.2%) is considered low.


Financial Health

How is Innospec's financial position?


Financial Position Analysis

Short Term Liabilities: IOSP's short term assets ($683.0M) exceed its short term liabilities ($308.3M).

Long Term Liabilities: IOSP's short term assets ($683.0M) exceed its long term liabilities ($191.0M).


Debt to Equity History and Analysis

Debt Level: IOSP is debt free.

Reducing Debt: IOSP has no debt compared to 5 years ago when its debt to equity ratio was 22.1%.

Debt Coverage: IOSP has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: IOSP has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Innospec current dividend yield, its reliability and sustainability?

1.23%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: IOSP's dividend (1.24%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.34%).

High Dividend: IOSP's dividend (1.24%) is low compared to the top 25% of dividend payers in the US market (3.49%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, IOSP has been paying a dividend for less than 10 years.

Growing Dividend: IOSP's dividend payments have increased, but the company has only paid a dividend for 8 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (29.2%), IOSP's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

9.5yrs

Average management tenure


CEO

Patrick Williams (56 yo)

12.75yrs

Tenure

US$7,454,445

Compensation

Mr. Patrick S. Williams serves as an Independent Director at AdvanSix Inc. since February 25, 2020. He has been the Chief Executive Officer and President at Innospec Inc. since April 2, 2009. He has been a...


CEO Compensation Analysis

Compensation vs Market: Patrick's total compensation ($USD7.45M) is above average for companies of similar size in the US market ($USD3.72M).

Compensation vs Earnings: Patrick's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: IOSP's management team is seasoned and experienced (9.5 years average tenure).


Board Members

Experienced Board: IOSP's board of directors are considered experienced (9.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: IOSP insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Innospec Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Innospec Inc.
  • Ticker: IOSP
  • Exchange: NasdaqGS
  • Founded: 1938
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Implied Market Cap: US$2.353b
  • Shares outstanding: 24.65m
  • Website: https://www.innospecinc.com

Number of Employees


Location

  • Innospec Inc.
  • 8310 South Valley Highway
  • Suite 350
  • Englewood
  • Colorado
  • 80112
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/20 23:52
End of Day Share Price2022/01/20 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.